What moved it
How to read these marks1 finding · 1 compound · 1 null · by evidence strength. No dose is advised.
Urine pH
Findings drawn, by strength
1finding · 1 compound
- Moderate1
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
Not pooled · no summary effect · point at a mark · Tab, then the arrow keys
Measured, no difference found1 finding
- InosineMoved: no difference foundEvidence: ModeratePaper: PMID 243661032014
- Who
- Adults with early Parkinson disease not yet requiring symptomatic treatment, serum urate below about 6 mg/dL, without gout, urolithiasis, or cardiovascular or renal disease, at US Parkinson Study Group sites; both inosine arms against placebo; urine pH self-monitored at least daily for the first 12 weeks, with potassium citrate alkalinisation in any arm for persistently acidic urine
- Dose studied
- inosine 500 mg capsules, started at 1 capsule twice daily and titrated up to 2 capsules three times daily (maximum 3 g/day) to serum urate 6.1-7.0 or 7.1-8.0 mg/dL; mean doses 1.18 and 1.51 g/day; up to 24 months
Need for alkalinization was rare because urine pH was unaffected by inosine (eTables 2 and 3).”
Quoted verbatim from Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.RCTPermalink
No row matches these filters.
How it is measured
pH of urine (urinary pH) by pH meter or reagent strip, in a spot sample or a timed (usually 24-hour) collection. The collection and the method are recorded with each finding.
Measured, with no finding
3 measurements
Show what was measuredHide what was measured
urine pH
no effect
Need for alkalinization was rare because urine pH was unaffected by inosine (eTables 2 and 3).
PMID 24366103 · one of two readings recorded this
urine pH
no effect
H3Cit did not significantly alter citraturia, calciuria, pH, or ammonium compared with placebo
PMID 30036516 · one of two readings recorded this
urine pH
increases, p = 0.01
Compared with placebo and H3Cit, K3Cit led to an increase in urine potassium, citrate and pH (, Table 2), and a decline in urine ammonium (Table 2) (p<0.01 for all)
PMID 30036516 · one of two readings recorded this
Papers about it
As an endpoint2
Show the papersHide the papers
Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
The Journal of urology2018PMID 30036516Via: named in the paper, as read
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
JAMA neurology2014PMID 24366103Via: named in the paper, as read
Newest
Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
The Journal of urology2018PMID 30036516As an endpoint
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
JAMA neurology2014PMID 24366103As an endpoint
Sources cited
1 paper